A phase 1 study of NTX-301, an oral DNMT1 inhibitor, in patients with MDS and AML (trial in progress).

NTX-301 - PinotBio, Aston Sci.

azacitidine - Generic mfg.

decitabine - Generic mfg.

https://meetings.asco.org/abstracts-presentations/213520

Pankit Vachhani; Guru Subramanian Guru Murthy; Omer Jamy; Kimo Bachiashvili; Sravanti Rangaraju; Tonya Cole; Corinne E Augelli-Szafran; Rebecca J Boohaker; Omar Moukha-Chafiq; Lynae J Hanks; Karr Stinson; Doo Young Jung; Ehab L. Atallah; Ravi Bhatia

Apr 28, 2022